Increase Your Practice Revenue With Venus Viva™’s Striae Alba Treatment


Striae Alba is among one of the top body-related concerns of patients today. New advances in NanoFractional and radio frequency technology have made some significant strides in Striae Alba treatments. 

As a medical aesthetics practitioner you know stretch marks are frustratingly difficult to treat. But recent academic research is pointing to a promising treatment. A study published in the Journal of Cosmetic Dermatology evaluated Venus Viva™ for treatment of striae alba, the chronic form of stretch marks.

The results were statistically significant, showing a reduction from baseline (p < 0.001) in total surface area, length and width of striae alba after three treatments at four-week intervals. Patient satisfaction scores of "Satisfied" and "Very Satisfied" for changes on texture, size, and overall improvement were 96.67%, 93.94% and 96.97% respectively.

The physicians' satisfaction showed concordant results that about 69.7% of all subjects had >50% improvement. Mean pain score was low at 2.33 (0 is no pain and 10 is intolerable pain). Post-inflammatory hyperpigmentation (PIH) was observed in 6 patients (18.1%), which improved with topical 4% hydroquinone. 

As 90 percent of women experience stretch marks, this represents significant new potential for Venus Viva™ and your practice. This may well be an opportunity to establish your office as a leader in this exciting treatment. Download the report by clicking on the button below to learn more!


Interested in learning more about Venus Concept devices and treatments?

Speak to an Expert